Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 2060-2069, 2007. First published October 19, 2007; 10.1373/clinchem.2007.090605
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Original Tables 1 & 2
Right arrow All Versions of this Article:
clinchem.2007.090605v1
53/12/2060    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cunat, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunat, S.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2007;53:2060-2069.)
© 2007 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders

Séverine Cunat1, Muriel Giansily-Blaizot1, Michael Bismuth2, François Blanc3, Olivier Dereure4, Dominique Larrey2, Alain Le Quellec5, Philippe Pouderoux6, Christian Rose7, Isabelle Raingeard8, Eric Renard8, Jean-François Schved1, Patricia Aguilar-Martinez1,a the CHU Montpellier AOI 2004 Working Group

1 Laboratory of Haematology, 2 Department of Hepatology, 3 Department of Internal Medicine E, 4 Department of Dermatology, 5 Department of Internal Medicine A, CHU of Montpellier, Montpellier, France.
6 Department of Hepato-Gastroenterology, CHU Nîmes, Nîmes, France.
7 Department of Oncology and Haematology, Lille University Hospital, Lille, France.
8 Department of Endocrinology, CHU of Montpellier, Montpellier, France.

aAddress correspondence to this author at: Laboratoire d’Hématologie, CHU de Montpellier, Hôpital Saint Eloi, 34295 Montpellier CEDEX 5, France. Fax 33-467-33-70-36; e-mail p-martinez{at}chu-montpellier.fr.

Background: New genetic forms of hereditary hemochromatosis (HH) or hereditary hyperferritinemia (HF) have been identified over the last few years, and abnormalities of various genes may interact in a single patient. This study aimed to develop a rapid automated method for sequencing the main genes involved.

Methods: We used a standard 96-well microplate with a single PCR condition in an adaptation of the SCAIP (single-condition amplification with internal primer) method to sequence the HFE (hemochromatosis), HAMP (hepcidin antimicrobial peptide), HFE2/HJV [hemochromatosis type 2 (juvenile)], SLC40A1 (ferroportin), and TFR2 (transferrin receptor 2) genes, and the 5' untranslated region of the FTL (ferritin, light polypeptide) gene. To further simplify the method, we adjusted PCR conditions to avoid the use of an internal primer and applied this single-condition amplification method to 38 selected, unrelated patients. We tailored the genetic investigation according to the clinical picture, with the patients falling into 2 groups. Group 1 consisted of patients with hyperferritinemia and high transferrin saturation (TS) (classic adult and juvenile HH forms, groups 1A and 1B, respectively), and group 2 consisted of patients with hyperferritinemia and low, typical, or slightly increased TS, with or without iron overload (groups 2A and 2B, respectively).

Results: With this strategy we identified single-gene and multigene abnormalities, including 6 previously undescribed abnormalities in HFE (c.794dupA), HFE2 (c.–89–4dupT), and SLC40A1 (c.262A>G, c.533G>A, c.1468G>A, and c.–59_–45del).

Conclusion: This method is a simple approach for investigating hereditary iron overload or HF and allows rapid evaluation of patients.




The following articles in journals at HighWire Press have cited this article:


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
P. Aguilar-Martinez, S. Cunat, F. Becker, F. Blanc, M. Nourrit, P. Pouderoux, and J.-F. Schved
Iron Overload in C282Y Heterozygotes: Identification of New Rare HFE Gene Mutants and a Step Strategy for Diagnosis.
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 1859 - 1859.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.